Loading...
PhD Anja Pišlar

PhD Anja Pišlar
no.: 32035 source: ARIS

researcher – active in research organisation
E-mail anja.pislarat signffa.uni-lj.si
Research activity

Code Science Field Subfield
4.06.00  Biotechnical sciences  Biotechnology   
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Points
524.66
A''
13.96
A'
313.15
A1/2
391.51
CI10
1,320
CImax
205
h10
21
A1
1.88
A3
0
Data for the last 5 years (citations for the last 10 years) on April 19, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 47  1,482  1,250  26.6 
Scopus 48  1,562  1,324  27.58 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Selena Horvat  Bologna doctoral studies    55893 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2009 
Doctor's degree  Ph. D.     SI University of Ljubljana, Faculty of Pharmacy 2013 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position ecris.org.employ_rolegroup Title
Full time employment (100%, RD:100%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry  10/11/2009  Assistant  Researcher  Associate professor 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J1-2484  Development of antibacterial compounds targeting validated enzymes in peptidoglycan biosynthesis   2020 - 2023  PhD Stanislav Gobec  3,861 
2. N1-0277  Research of multifunctional compounds targeting neuroinflammation and cholinergic deficit in Alzheimer's disease   2023  PhD Stanislav Gobec  1,060 
3. J3-3071  Cathepsins B and X in breast cancer stem cells – molecular targets and relevance for antitumor therapy   2021 - 2023  PhD Ana Mitrović  2,651 
4. J4-1776  Improvement of immunotherapeutic potential of NK cells through modulation of cystatin F   2019 - 2022  PhD Janko Kos  2,921 
5. J4-9327  Targeting, imaging and treating of colorectal cancer with safe theranostic bacteria   2020 - 2021  PhD Aleš Berlec  2,467 
6. J3-9267  Inhibition of cathepsin X activity as a novel strategy for the treatment of Parkinson's disease   2018 - 2021  PhD Anja Pišlar  2,722 
7. J4-8227  Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy   2017 - 2020  PhD Janko Kos  4,549 
8. L1-8157  Development of multifunctional compounds for treatment of Alzheimer's disease   2017 - 2020  PhD Stanislav Gobec  4,688 
9. J4-6811  The role of cysteine protease inhibitors in NK cell mediated lysis of tumour cells   2015 - 2017  PhD Janko Kos  2,436 
10. J1-5450  Protein engineering of recombinant probiotic lactic acid bacteria for treatment of irritative bowel disease   2016  PhD Borut Štrukelj  2,441 
11. J4-5529  Nitroxoline and its derivatives as new antitumour drugs   2013 - 2016  PhD Janko Kos  5,945 
12. J4-4123  Inhibitors of cysteine carboxypeptidases as regulators of autoimmune and neurodegenerative processes   2011 - 2014  PhD Janko Kos  6,316 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P4-0127  Pharmaceutical biotechnology: Science for health   2019 - 2024  PhD Janko Kos  5,044 
2. P4-0127  Pharmaceutical biotechnology: Science for Health   2015 - 2018  PhD Janko Kos  4,938 
3. P4-0127  Farmacevtska biotehnologija: znanje za zdravje (Slovene)   2009 - 2014  PhD Janko Kos  5,413 
Views history
Favourite